🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Mineralys Therapeutics, Inc. (MLYS)
NASDAQ: MLYS · Real-Time Price · USD
13.66
-0.50 (-3.53%)
At close: Nov 20, 2026, 4:00 PM EST
13.70
+0.04 (0.29%)
After-hours: Nov 20, 2026, 7:30 PM EST

Mineralys Therapeutics Statistics

Total Valuation

MLYS has a market cap or net worth of $1.21 billion. The enterprise value is $683.29 million.

Market Cap1.21B
Enterprise Value 683.29M

Important Dates

The last earnings date was Wednesday, November 4, 2026, after market close.

Earnings Date Nov 4, 2026
Ex-Dividend Date n/a

Share Statistics

MLYS has 88.56 million shares outstanding. The number of shares has increased by 41.14% in one year.

Current Share Class 88.56M
Shares Outstanding 88.56M
Shares Change (YoY) +41.14%
Shares Change (QoQ) +5.03%
Owned by Insiders (%) 0.51%
Owned by Institutions (%) 88.27%
Float 66.75M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS 31.55
PB Ratio 2.40
P/TBV Ratio 2.40
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 11.83, with a Debt / Equity ratio of 0.20.

Current Ratio 11.83
Quick Ratio 11.77
Debt / Equity 0.20
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -96.88

Financial Efficiency

Return on equity (ROE) is -68.50% and return on invested capital (ROIC) is -41.34%.

Return on Equity (ROE) -68.50%
Return on Assets (ROA) -60.16%
Return on Invested Capital (ROIC) -41.34%
Return on Capital Employed (ROCE) -67.54%
Weighted Average Cost of Capital (WACC) 8.37%
Revenue Per Employee n/a
Profits Per Employee -$4.87M
Employee Count76
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -67.57% in the last 52 weeks. The beta is 0.83, so MLYS's price volatility has been lower than the market average.

Beta (5Y) 0.83
52-Week Price Change -67.57%
50-Day Moving Average 21.12
200-Day Moving Average 25.75
Relative Strength Index (RSI) 28.67
Average Volume (20 Days) 2,071,383

Short Selling Information

The latest short interest is 7.69 million, so 8.68% of the outstanding shares have been sold short.

Short Interest 7.69M
Short Previous Month 7.44M
Short % of Shares Out 8.68%
Short % of Float 11.52%
Short Ratio (days to cover) 5.01

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -389.75M
Pretax Income -369.97M
Net Income -369.97M
EBITDA -389.72M
EBIT -389.75M
Earnings Per Share (EPS) -$4.38
Full Income Statement

Balance Sheet

The company has $624.67 million in cash and $98.27 million in debt, with a net cash position of $526.40 million or $5.94 per share.

Cash & Cash Equivalents 624.67M
Total Debt 98.27M
Net Cash 526.40M
Net Cash Per Share $5.94
Equity (Book Value) 503.78M
Book Value Per Share 5.69
Working Capital 574.92M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$153.01 million and capital expenditures -$15,000, giving a free cash flow of -$153.03 million.

Operating Cash Flow -153.01M
Capital Expenditures -15,000
Depreciation & Amortization 30,000
Net Borrowing 97.50M
Free Cash Flow -153.03M
FCF Per Share -$1.73
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

MLYS does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
FCF Payout Ratio n/a
Buyback Yield -41.14%
Shareholder Yield -41.14%
Earnings Yield -32.07%
FCF Yield -12.65%

Analyst Forecast

The average price target for MLYS is $43.56, which is 218.89% higher than the current price. The consensus rating is "Strong Buy".

Price Target $43.56
Price Target Difference 218.89%
Analyst Consensus Strong Buy
Analyst Count 11
Revenue Growth Forecast (3Y) n/a
EPS Growth Forecast (3Y) n/a
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a
Graham Formula Value n/a
Graham Formula Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score 1